The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Chaumiere Consultadoria & Servicos Sdc Unipessoal since 2008.
The trader's CIK number is 1330564.
At the time of the last reporting, Chaumiere Consultadoria & Servicos Sdc Unipessoal was the Officer of Regenerx Biopharmaceuticals Inc. (stock ticker symbol RGRX).
Also see all insider trading activities at Regenerx Biopharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2009 | RGN | 2,584,643 | $1,724,998 | 0 | $0 | 0 | $0 |
| 2008 | RGN | 1,034,482 | $1,499,998 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | QCOR | 0 | $0 | 2,339,338 | $11,585,956 | 0 | $0 |
1. Regenerx Biopharmaceuticals Inc (RGN)
2. Questcor Pharmaceuticals Inc (QCOR)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-10-08 | RGN | Buy | 1,219,512 | .82 | 999,999 |
| 2009-06-02 | RGN | Buy | 312,500 | .40 | 125,000 |
| 2009-04-13 | RGN | Buy | 1,052,631 | .57 | 599,999 |
| 2008-12-10 | RGN | Buy | 1,034,482 | 1.45 | 1,499,998 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-08-13 | QCOR | Sale | 2,200,000 | 4.95 | 10,890,000 |
| 2008-07-16 | QCOR | Sale | 100,000 | 4.91 | 491,399 |
| 2008-07-02 | QCOR | Sale | 31,338 | 5.20 | 162,957 |
| 2008-06-06 | QCOR | Sale | 3,900 | 5.20 | 20,280 |
| 2008-06-05 | QCOR | Sale | 4,100 | 5.20 | 21,320 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chaumiere Consultadoria & Servicos Sdc Unipessoal (Officer of Regenerx Biopharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.